Canopy Growth (CGC) Treasury Shares (2018 - 2026)
Canopy Growth (CGC) reported Treasury Shares of $2.1 million for Q1 2026, up 124.91% on a YoY basis from $947586.9 in Q1 2025, and down 5.67% sequentially from $2.3 million in Q4 2025.
Canopy Growth (CGC) Treasury Shares (2018 - 2026) Analysis & Trends
Canopy Growth (CGC) has 9 years of Treasury Shares data on file, last reported at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 124.91% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 124.91% YoY), and the FY2026 full-year result was $2.1 million, up 124.91% from the prior year.
- Treasury Shares slipped to $2.1 million in Q1 2026, from $2.3 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $11.5 million in Q3 2023 to a low of $191079.8 in Q1 2023.
- A 5-year average of $2.4 million and a median of $1.3 million in 2024 frame the typical range for Treasury Shares.
- Peak annual rise in Treasury Shares reached 394.13% in 2024, while the deepest fall reached 90.63% in 2024.
- Tracing CGC's Treasury Shares over 5 years: stood at $3.2 million in 2022, then slumped by 67.67% to $1.0 million in 2023, then declined by 0.1% to $1.0 million in 2024, then soared by 119.73% to $2.3 million in 2025, then retreated by 5.67% to $2.1 million in 2026.
- Business Quant data shows CGC's Treasury Shares at $2.1 million in Q1 2026, $2.3 million in Q4 2025, and $2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | 2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Mn |
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 947,586.88 |
| Mar 31, 2025 | 947,586.88 |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 944,189.89 |
| Mar 31, 2024 | 944,189.89 |
| Dec 31, 2023 | 1.03 Mn |
| Dec 31, 2023 | 1.03 Mn |